D.Douglas Miller

595 total citations
11 papers, 402 citations indexed

About

D.Douglas Miller is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, D.Douglas Miller has authored 11 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 5 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Surgery. Recurrent topics in D.Douglas Miller's work include Cardiac Imaging and Diagnostics (5 papers), Cardiac, Anesthesia and Surgical Outcomes (2 papers) and Receptor Mechanisms and Signaling (2 papers). D.Douglas Miller is often cited by papers focused on Cardiac Imaging and Diagnostics (5 papers), Cardiac, Anesthesia and Surgical Outcomes (2 papers) and Receptor Mechanisms and Signaling (2 papers). D.Douglas Miller collaborates with scholars based in United States and Belgium. D.Douglas Miller's co-authors include Leslee J. Shaw, B.J. Gersh, Mustafa Z Younis, Henry G. Stratmann, Mark D. Wittry, Rory Hachamovitch, Daniel S. Berman, Gary V. Heller, Thomas H. Marwick and Mark I. Travin and has published in prestigious journals such as Journal of the American College of Cardiology, Journal of Medicinal Chemistry and The American Journal of Cardiology.

In The Last Decade

D.Douglas Miller

11 papers receiving 382 citations

Peers

D.Douglas Miller
J Cosyns Belgium
W. L. Proudfit United States
Amira Hassanein United States
Frans J.Th Wackers United States
Ali M. Kizilbash United States
Nicholas J. Miele United States
T P Gavaghan Australia
James McGowan United Kingdom
J Cosyns Belgium
D.Douglas Miller
Citations per year, relative to D.Douglas Miller D.Douglas Miller (= 1×) peers J Cosyns

Countries citing papers authored by D.Douglas Miller

Since Specialization
Citations

This map shows the geographic impact of D.Douglas Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.Douglas Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.Douglas Miller more than expected).

Fields of papers citing papers by D.Douglas Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.Douglas Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.Douglas Miller. The network helps show where D.Douglas Miller may publish in the future.

Co-authorship network of co-authors of D.Douglas Miller

This figure shows the co-authorship network connecting the top 25 collaborators of D.Douglas Miller. A scholar is included among the top collaborators of D.Douglas Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.Douglas Miller. D.Douglas Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Hachamovitch, Rory, et al.. (1999). Using an outcomes-based approach to identify candidates for risk stratification after exercise treadmill testing. Journal of General Internal Medicine. 14(1). 1–9. 28 indexed citations
2.
Heller, Gary V., Mark I. Travin, Michael S. Lauer, et al.. (1999). Cost analysis of diagnostic testing for coronary artery disease in women with stable chest pain. Journal of Nuclear Cardiology. 6(6). 559–569. 59 indexed citations
3.
Konkar, Anish, Gamal Shams, Weiping Zheng, et al.. (1999). β-Adrenoceptor Subtype Activities of Trimetoquinol Derivatives: Biochemical Studies on Human β-Adrenoceptors Expressed in Chinese Hamster Ovary Cells. Journal of Pharmacology and Experimental Therapeutics. 291(2). 875–883. 8 indexed citations
4.
Shaw, Leslee J., et al.. (1996). Meta-analysis of intravenous dipyridamole-thallium-201 imaging (1985 to 1994) and dobutamine echocardiography (1991 to 1994) for risk stratification before vascular surgery. Journal of the American College of Cardiology. 27(4). 787–798. 150 indexed citations
5.
Miller, D.Douglas, Richard G. Bach, Fermin O. Tio, et al.. (1996). Interleukin-2 receptor-specific fusion toxin inhibits barotrauma-induced arterial atherosclerosis. Atherosclerosis. 126(1). 1–14. 5 indexed citations
6.
Stratmann, Henry G., et al.. (1994). Prognostic value of dipyridamole technetium-99m sestamibi myocardial tomography in patients with stable chest pain who are unable to exercise. The American Journal of Cardiology. 73(9). 647–652. 68 indexed citations
7.
Younis, Mustafa Z, et al.. (1993). Comparison of the Asymptomatic Cardiac Ischemia Pilot and modified Asymptomatic Cardiac Ischemia Pilot versus Bruce and Cornell exercise protocols. The American Journal of Cardiology. 72(9). 715–720. 51 indexed citations
8.
Shams, Gamal, Lane J. Wallace, D.Douglas Miller, & Dennis R. Feller. (1990). Effects of Thromboxane A<sub>2</sub> on Thoracic Aorta of Young and Old Rats: Use of Selective Thromboxane Receptor Antagonists. Pharmacology. 40(1). 27–32. 4 indexed citations
9.
Shams, Gamal, et al.. (1990). Pharmacological evaluation of the β-adrenoceptor agonist and thromboxane receptor blocking properties of 1-benzyl substituted trimetoquinol analogues. European Journal of Pharmacology. 184(1). 21–31. 6 indexed citations
10.
Miller, D.Douglas, Donald L. Johnston, John Newell, et al.. (1989). Effect of hyperosmotic mannitol on magnetic resonance relaxation parameters in reperfused canine myocardial infarction. Magnetic Resonance Imaging. 7(1). 79–88. 16 indexed citations
11.
Romstedt, Karl, et al.. (1988). Synthesis and thromboxane A2 antagonist activity of N-benzyltrimetoquinol analogs. Journal of Medicinal Chemistry. 31(8). 1506–1512. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026